** Shares of Medibank Private MPL.AX rise as much as 3.9% to a record high of A$4.502, last up 2.8%
** UBS hikes price target for insurer to A$4.90 from A$4.30, rates stock "Buy"
** Brokerage sees scope for gross margins to expand further into FY26E, given that premium rate rises are set to continue outpacing inflation in near term
** Three of 10 analysts rate the stock "buy" and seven "hold"; median PT is A$4.46 – data compiled by LSEG
** Stock up 17.9% this year
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。